» Articles » PMID: 16912122

Autoimmune Thyroiditis and Exposure to Iodine 131 in the Ukrainian Cohort Study of Thyroid Cancer and Other Thyroid Diseases After the Chornobyl Accident: Results from the First Screening Cycle (1998-2000)

Abstract

Context: Due to the Chornobyl accident, millions were exposed to radioactive isotopes of iodine and some received appreciable iodine 131 (131I) doses. A subsequent increase in thyroid cancer has been largely attributed to this exposure, but evidence concerning autoimmune thyroiditis (AIT) remains inconclusive.

Objective: The objective of the study was to quantify risk of AIT after 131I exposure.

Design/setting/participants: Baseline data were collected from the first screening cycle (1998-2000) of a large cohort of radiation-exposed individuals (n = 12,240), residents of contaminated, iodine-deficient territories of Ukraine. Study individuals were under the age of 18 yr on April 26, 1986, and had thyroid radioactivity measurements made shortly after the accident.

Outcomes: AIT was defined a priori based on various combinations of elevated antibodies to thyroid peroxidase (ATPO), TSH, and clinical findings; elevated ATPO were considered to be an indicator of thyroid autoimmunity.

Results: No significant association was found between 131I thyroid dose estimates and AIT, but prevalence of elevated ATPO demonstrated a modest, significant association with 131I that was well described by several concave models. This relationship was apparent in individuals with moderately elevated ATPO and euthyroid, thyroid disease-free individuals.

Conclusions: Twelve to 14 yr after the Chornobyl accident, no radiation-related increase in prevalence of AIT was found in a large cohort study, the first in which 131I thyroid doses were estimated using individual radioactivity measurements. However, a dose-response relationship with ATPO prevalence raises the possibility that clinically important changes may occur over time. Thus, further follow-up and analysis of prospective data in this cohort are necessary.

Citing Articles

A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure.

Little M, Bazyka D, Berrington de Gonzalez A, Brenner A, Chumak V, Cullings H Radiat Res. 2024; 202(2):432-487.

PMID: 39021204 PMC: 11316622. DOI: 10.1667/RADE-24-00021.1.


Diagnosis and therapeutic approach to bone health in patients with hypopituitarism.

Kuliczkowska-Plaksej J, Zdrojowy-Welna A, Jawiarczyk-Przybylowska A, Gojny L, Bolanowski M Rev Endocr Metab Disord. 2024; 25(3):513-539.

PMID: 38565758 DOI: 10.1007/s11154-024-09878-w.


Association between exposure to radioactive iodine after the Chernobyl accident and thyroid volume in Belarus 10-15 years later.

Chirikova E, McConnell R, OKane P, Yauseyenka V, Little M, Minenko V Environ Health. 2022; 21(1):5.

PMID: 34996456 PMC: 8742457. DOI: 10.1186/s12940-021-00820-0.


Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment.

Xing Y, Zhang K, Jin G Biosci Rep. 2019; 40(1).

PMID: 31840740 PMC: 6944668. DOI: 10.1042/BSR20191609.


Radiation-related thyroid autoimmunity and dysfunction.

Nagayama Y J Radiat Res. 2017; 59(suppl_2):ii98-ii107.

PMID: 29069397 PMC: 5941148. DOI: 10.1093/jrr/rrx054.